We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > cephalosporin

News List

Cefdinir API Market Size & Trends PharmaSources
July 13, 2021
Cefdinir is a 3rd generation cephalosporin (antibiotic). It is used to treat gram-negative and gram-positive infections of the sinus, throat, lungs, skin, and ear.
Where can you find the bulk price of Cefazolin Sodium API Powder? PharmaSources
June 22, 2021
Cefazolin sodium is a broad-spectrum beta-lactam antibiotic belonging to the cephalosporin class of antibiotics.
Sandoz to acquire GlaxoSmithKline’s cephalosporin antibiotics business pharmaceutical-business-review
February 20, 2021
Global leader in antibiotics and a division of Swiss multinational pharma company Novartis, Germany-based Sandoz has signed a contract to acquire GlaxoSmithKline’s (GSK) cephalosporin antibiotics.
Global cephalosporin drugs market projected to rise 3.34 percent europeanpharmaceuticalreview
August 20, 2019
The worldwide trade of the cephalosporin class of antibiotics will increase to $14.1 billion by the end of 2025.